![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | affects expression | ISO | RGD:731861 | 6480464 | 1, 2-Dimethylhydrazine affects the expression of GALNT7 mRNA | CTD | PMID:22206623 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GALNT7 mRNA | CTD | PMID:26496021 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731861 | 6480464 | [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of GALNT7 mRNA | CTD | PMID:19465110 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GALNT7 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GALNT7 mRNA | CTD | PMID:34747641 | 3-methylcholanthrene | increases expression | ISO | RGD:731861 | 6480464 | Methylcholanthrene results in increased expression of GALNT7 mRNA | CTD | PMID:20713471 | 4,4'-diaminodiphenylmethane | affects expression | ISO | RGD:731861 | 6480464 | 4, 4'-diaminodiphenylmethane affects the expression of GALNT7 mRNA | CTD | PMID:18648102 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:731861 | 6480464 | Fenretinide results in increased expression of GALNT7 mRNA | CTD | PMID:28973697 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GALNT7 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of GALNT7 mRNA | CTD | PMID:28959563 | aflatoxin B1 | affects expression | ISO | RGD:1347952 | 6480464 | Aflatoxin B1 affects the expression of GALNT7 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | ISO | RGD:1347952 | 6480464 | Aflatoxin B1 results in increased expression of GALNT7 mRNA | CTD | PMID:27153756 | aflatoxin B1 | decreases expression | ISO | RGD:731861 | 6480464 | Aflatoxin B1 results in decreased expression of GALNT7 mRNA | CTD | PMID:19770486 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of GALNT7 mRNA | CTD | PMID:16483693 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of GALNT7 mRNA | CTD | PMID:30779732 | aristolochic acid | decreases expression | ISO | RGD:1347952 | 6480464 | aristolochic acid I results in decreased expression of GALNT7 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | RGD:1347952 | 6480464 | Arsenic affects the methylation of GALNT7 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1347952 | 6480464 | Arsenic affects the methylation of GALNT7 gene | CTD | PMID:25304211 | benzo[a]pyrene | increases expression | ISO | RGD:1347952 | 6480464 | Benzo(a)pyrene results in increased expression of GALNT7 mRNA | CTD | PMID:20106945, PMID:32234424 | benzo[a]pyrene | affects expression | ISO | RGD:731861 | 6480464 | Benzo(a)pyrene affects the expression of GALNT7 mRNA | CTD | PMID:21715664 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1347952 | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of GALNT7 mRNA | CTD | PMID:26496021 | bisphenol A | multiple interactions | ISO | RGD:1347952 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of GALNT7 gene | CTD | PMID:31601247 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GALNT7 mRNA | CTD | PMID:34947998 | butanal | decreases expression | ISO | RGD:1347952 | 6480464 | butyraldehyde results in decreased expression of GALNT7 mRNA | CTD | PMID:26079696 | cadmium atom | increases expression | ISO | RGD:1347952 | 6480464 | Cadmium results in increased expression of GALNT7 mRNA | CTD | PMID:23369406 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of GALNT7 promoter | CTD | PMID:22457795 | carbamazepine | affects expression | ISO | RGD:1347952 | 6480464 | Carbamazepine affects the expression of GALNT7 mRNA | CTD | PMID:25979313 | chlordecone | increases expression | ISO | RGD:731861 | 6480464 | Chlordecone results in increased expression of GALNT7 mRNA | CTD | PMID:33711761 | choline | multiple interactions | ISO | RGD:731861 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GALNT7 gene | CTD | PMID:20938992 | cisplatin | affects response to substance | ISO | RGD:1347952 | 6480464 | GALNT7 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | cobalt dichloride | decreases expression | ISO | RGD:1347952 | 6480464 | cobaltous chloride results in decreased expression of GALNT7 mRNA | CTD | PMID:19320972 | coumestrol | multiple interactions | ISO | RGD:1347952 | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | decreases expression | ISO | RGD:1347952 | 6480464 | Coumestrol results in decreased expression of GALNT7 mRNA | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | RGD:1347952 | 6480464 | Cyclosporine results in increased expression of GALNT7 mRNA | CTD | PMID:20106945 | dextran sulfate | multiple interactions | ISO | RGD:731861 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT7 mRNA | CTD | PMID:29950665 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of GALNT7 mRNA | CTD | PMID:29391264 | Enterolactone | multiple interactions | ISO | RGD:1347952 | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of GALNT7 mRNA | CTD | PMID:19167446 | ethyl methanesulfonate | decreases expression | ISO | RGD:1347952 | 6480464 | Ethyl Methanesulfonate results in decreased expression of GALNT7 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | RGD:731861 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GALNT7 gene | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | RGD:1347952 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of GALNT7 gene | CTD | PMID:31601247 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of GALNT7 mRNA | CTD | PMID:22061828, PMID:33387578 | hydralazine | multiple interactions | ISO | RGD:1347952 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of GALNT7 mRNA | CTD | PMID:17183730 | imidacloprid | increases expression | EXP | | 6480464 | imidacloprid results in increased expression of GALNT7 mRNA | CTD | PMID:27782041 | isoflavones | decreases expression | ISO | RGD:1347952 | 6480464 | Isoflavones results in decreased expression of GALNT7 mRNA | CTD | PMID:17374662 | isoflurane | increases methylation | ISO | RGD:731861 | 6480464 | Isoflurane results in increased methylation of GALNT7 mRNA | CTD | PMID:35249202 | L-methionine | multiple interactions | ISO | RGD:731861 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of GALNT7 gene | CTD | PMID:20938992 | methyl methanesulfonate | decreases expression | ISO | RGD:1347952 | 6480464 | Methyl Methanesulfonate results in decreased expression of GALNT7 mRNA | CTD | PMID:23649840 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:731861 | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of GALNT7 mRNA | CTD | PMID:22401849 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GALNT7 mRNA | CTD | PMID:25729387 | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of GALNT7 mRNA | CTD | PMID:25729387 | paclitaxel | affects response to substance | ISO | RGD:1347952 | 6480464 | GALNT7 protein affects the susceptibility to Paclitaxel | CTD | PMID:16217747 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of GALNT7 mRNA | CTD | PMID:33387578 | potassium chromate | decreases expression | ISO | RGD:1347952 | 6480464 | potassium chromate(VI) results in decreased expression of GALNT7 mRNA | CTD | PMID:22714537 | resveratrol | multiple interactions | ISO | RGD:1347952 | 6480464 | [Coumestrol co-treated with Resveratrol] results in decreased expression of GALNT7 mRNA, [Plant Extracts co-treated with Resveratrol] results in increased expression of GALNT7 mRNA | CTD | PMID:19167446, PMID:23557933 | sodium arsenate | increases expression | ISO | RGD:731861 | 6480464 | sodium arsenate results in increased expression of GALNT7 mRNA | CTD | PMID:21795629 | sodium arsenite | affects methylation | ISO | RGD:1347952 | 6480464 | sodium arsenite affects the methylation of GALNT7 gene | CTD | PMID:28589171 | sodium arsenite | decreases expression | ISO | RGD:1347952 | 6480464 | sodium arsenite results in decreased expression of GALNT7 mRNA | CTD | PMID:28595984, PMID:34032870 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of GALNT7 mRNA | CTD | PMID:19281266 | succimer | multiple interactions | ISO | RGD:731861 | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GALNT7 mRNA | CTD | PMID:26378955 | succimer | multiple interactions | ISO | RGD:1347952 | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GALNT7 mRNA | CTD | PMID:26378955 | titanium dioxide | multiple interactions | ISO | RGD:731861 | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT7 mRNA | CTD | PMID:29950665 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of GALNT7 mRNA | CTD | PMID:25729387 | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of GALNT7 protein | CTD | PMID:32519852 | valproic acid | increases methylation | ISO | RGD:1347952 | 6480464 | Valproic Acid results in increased methylation of GALNT7 gene | CTD | PMID:29154799 | valproic acid | multiple interactions | ISO | RGD:1347952 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of GALNT7 mRNA | CTD | PMID:17183730 | valproic acid | decreases expression | ISO | RGD:1347952 | 6480464 | Valproic Acid results in decreased expression of GALNT7 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | RGD:1347952 | 6480464 | Valproic Acid affects the expression of GALNT7 mRNA | CTD | PMID:25979313 | |